Task A63: Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus

NIH RePORTER · NIH · N01 · $849,562 · view on reporter.nih.gov ↗

Abstract

This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.

Key facts

NIH application ID
11042000
Project number
272201700040I-P00004-759302200001-1
Recipient
UNIVERSITY OF TEXAS MED BR GALVESTON
Principal Investigator
DAVID BEASLEY
Activity code
N01
Funding institute
NIH
Fiscal year
2024
Award amount
$849,562
Award type
Project period
2021-11-04 → 2024-11-03